ThermoFisherScientific - Custom and Bulks
Pharma Focus Europe
Worldwide Clinical Trials - Oncology

LATEST NEWSRead more...

20

May 2024

Virios Therapeutics Prices $1.7 Million Public Offering of Common Stock, Prepares for IMC-2 Long-COVID Phase 2b Study

Virios Therapeutics Inc a biotechnology firm focused on developing novel antiviral treatments for chronic illnesses such as fibromyalgia and LongCOVID has disclosed the pricing of its previously

17

May 2024

A2 Bio Commences EVEREST-2 Phase 1 Clinical Trial with Initial Patient Administered Novel Mesothelin Logic-Gated CAR T Therapy

A Biotherapeutics Inc has initiated the Phase clinical trial for AB marking a significant milestone in the development of its innovative cell therapy This clinicalstage company specializes

17

May 2024

Accelerated Biosciences and Spanios Announce Partnership to Improve Therapeutic Approaches for Solid Tumor Cancers

Spanios a company known for its unique D tumoroid platforms used to validate solid tumor therapies has announced a new partnership with Accelerated Biosciences Accelerated Biosciences

16

May 2024

Aulos Bioscience Collaborates with Merck KGaA, Darmstadt, Germany for Joint Clinical Trial on Bavencio® and AU-007 Combination

Aulos Bioscience a company in immunooncology striving to transform cancer treatment with innovative IL therapeutics has announced a significant collaboration with Ares Trading SA a Swiss subsidiary

15

May 2024

Verismo Therapeutics Obtains FDA Clearance for SynKIR™-310 in Relapsed/Refractory B-cell NHL

Verismo Therapeutics has received approval from the US Food and Drug Administration to proceed with the Phase clinical trial of SynKIR for NHL This trial named CELESTIAL will evaluate the safety

15

May 2024

FogPharma and ARTBIO Announce Partnership for the Development of Multiple Helicon™-Enabled Alpha-Particle Radioligand Therapies in Cancer Treatment

FogPharma and ARTBIO Inc are collaborating to develop advanced therapies for various cancers FogPharma renowned for its innovative Helicon peptide platform and ARTBIO

press releasesRead more...

ERS Genomics and IRBM Sign CRISPR/Cas9 License Agreement

ERS Genomics Limited the CRISPR licensing Company and IRBM a leader in the field of drug discovery today announced a nonexclusive CRISPRCas license agreement The agreement grants IRBM access to ERS CRISPRCas patent

Marinus Pharmaceuticals Announces Key Business Updates for Tuberous Sclerosis Complex Program

Marinus Pharmaceuticals Inc a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders today announced completion of enrollment in the global

FDA Approves IMDELLTRA™ (Tarlatamab-dlle), the First and Only T-cell Engager Therapy for the Treatment of Extensive-stage Small Cell Lung Cancer

Amgen today announced that the US Food and Drug Administration has approved IMDELLTRA for the treatment of adult patients with extensivestage small cell lung

Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial

Tourmaline Bio Inc a latestage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients

20 - 22

May 2024

20 - 21

May 2024

21 - 23

May 2024

21 - 23

May 2024

21 - 23

May 2024

21 - 21

May 2024

21 - 23

May 2024

21 - 22

May 2024
Oliver Healthcare Packaging Pharmaceutical Solutions
ThermoFisher - Mastering API production at every scale
Future Labs Live - 2024
World Orphan Drug Congress 2024
World Vaccine Congress Europe 2024
Sartorius Webinar - Pave Your Weigh to Accurate Analytical Results
patheon - Revolutionizing Pharma

TOP ARTICLES

  • 1

    Pharma Safety in Sterile Fill-Finish: Ensuring Quality and Compliance

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 2

    How Pharmacoepidemiology Drives Clinical Research: Exploring Trends and Insights

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 3

    Navigating Gene Therapy Regulations: Compliance Strategies for Successful Implementation

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 4

    Efficiency in Bioprocessing: Unveiling Upstream and Downstream Operations

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 5

    Digital Twins: The Future Blueprint for Pharmaceutical Production

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

KNOWLEDGE BANK

  • Research Insights

    In Silico Product Design Of Pharmaceuticals

    AbstractThe increasing demand for personalized medicine necessitates the production of easily customizable dosage forms As the number of possible dosage forms may scale toward infinity their uniqueness requires a versatile production platform and numerical simulation in order to be manufactured efficiently A mathematical description of these systems is the only

EDITORIAL SECTION